key: cord-1038230-h01vu66i
authors: Nambou, Komi; Anakpa, Manawa
title: Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19
date: 2020-07-22
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2020.104471
sha: c784b91af2c618e3911b2a0a92ff5248c8ef218c
doc_id: 1038230
cord_uid: h01vu66i

Coronavirus disease 2019 (COVID-19) has caused thousands of deaths worldwide and has become an urgent public health concern. The extraordinary interhuman transmission of this disease has urged scientists to examine the various facets of its pathogenic agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, based on publicly available genomic data, we analyzed the codon usage co-adaptation profiles of SARS-CoV-2 and other respiratory coronaviruses (CoVs) with their human host, identified CoV-responsive human genes and their functional roles on the basis of both the relative synonymous codon usage (RSCU)-based correlation of viral genes with human genes and differential gene expression analysis, and predicted potential drugs for COVID-19 treatment based on these genes. The relatively high codon adaptation index (CAI) values (>0.70) signposted the gene expressivity efficiency of CoVs in human. The ENc-GC3 plot indicated that SARS-CoV-2 genome was under strict selection pressure while SARS-CoV and MERS-CoV were under selection and mutational pressures. The RSCU-based correlation analysis indicated that the viral genomes shared similar codons with a panoply of human genes. The merging of RSCU-based correlation data and SARS-CoV-2-responsive differentially expressed genes allowed the identification of human genes potentially affected by SARS-CoV-2 infection. Functional enrichment analysis indicated that these genes were enriched in biological processes and pathways related to host response to viral infection and immune response. Using the drug-gene interaction database, we screened a list of drugs that could target these genes as potential COVID-19 therapeutics. Our findings not only will contribute in vaccine development but also provide a useful set of drugs that could guide practitioners in strategical monitoring of COVID-19. We recommend practitioners to scrupulously screen this list of predicted drugs in order to authenticate those qualified for treating COVID-19 symptoms.

The coronaviruses (CoVs) are a large family of RNA viruses responsible for illnesses ranging from the common cold to severe acute respiratory diseases both in wild animals and humans (Sutton and Subbarao, 2015; Tortorici and Veesler, 2019) .

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a CoV identified as the causal agent of the respiratory epidemic first detected in China (Wuhan) and subsequently declared by the World Health Organization (WHO) as the COVID-19 pandemics due to the spread of the outbreak to other countries worldwide (Lai et al., 2020; Zheng, 2020) . The clinical symptoms of SARS-CoV-2 infection include fever, cough, headache, and shortness of breath (Lin et al., 2020; Xu et al., 2020; Yang et al., 2020; . COVID-19 has caused a significant loss in human lives and has resulted in a tremendous economic damage across the five continents (Ahn et al., 2020) . At present, there is no accurate therapy for COVID-19 though some medications such as chloroquine/hydroxychloroquine (Wright et al., 2020) , combinations of antiviral and anti-inflammatory treatments (Stebbing et al., 2020) , traditional Chinese medicine (Ren et al., 2020) and other therapeutics (Ahn et al., 2020; Elfiky, 2020) have been proposed. The development of vaccines against comparative genomics studies suggested the divergence between SARS-CoV-2 and other CoVs, namely SARS-CoV and MERS-CoV . Codon usage bias, the differential use of codons encoding a given amino acid, is vital for examining the expressivity and the adaptation of exogenous viral genes to the hosts (Deb et al., 2020; Oldfield et al., 2020; Yao et al., 2019) . Codon usage can play a significant role in modulating the expression of viral genes via codon optimization (Morgunov and Babu, 2014; Victor et al., 2019; Zalucki et al., 2009) . Codon usage is equally important for studying the evolution and ecological adaptation of diverse organisms (Liang et al., 2014; Ou et al., 2020) . Studies on codon usage analysis of CoVs have been focused on the analysis of codon usage bias of some proteins among CoVs (Castells et al., 2017; Chen et al., 2017; Gu et al., 2004; Kandeel and Altaher, 2017; Sheikh et al., 2020) . With the outbreak of COVID-19, scientists have put forward effort to analyze the codon usage bias of CoVs in order to improve our understanding on the emergence, adaptation, spread and evolution of SARS- CoV-2 (Tort et al., 2020) .

Apart from that, the phenotypic variation of genes encoded by SARS-CoV-2 has been also studied (Dilucca et al., 2020) . Nonetheless, little is known about the molecular mechanism associated with the SARS-CoV-2 and its adaptation to its human host. Therefore, studies on the codon usage pattern of SARS-CoV-2 would be vital in elucidating the evolution of SARS-CoV-2, its adaptation to the host and the molecular mechanism involved in SARS-CoV-2 infection and pathological changes in the host. vaccine and therapeutic drug development. Previous studies indicated that codon usage preferences of viruses and their animal and human hosts are strongly correlated, especially in tissues they infect (Miller et al., 2017) . These correlations are the consequence of co-evolution between the virus and their host, which is necessary for the host evolution in the defense against the virus as well as the virus adaptation to the host physiological changes (Guo et al., 2019; Miller et al., 2017) . Thus, the analysis of codon usage is important for uncovering the host genes which are affected by the viral infection. The knowledge on these genes is necessary for determining the mechanisms underlying the pathogenesis associated with viral infection in the host.

Systems biology is a multidisciplinary method that is systematically used for portraying the multifaceted aspects of biological processes and accurate prediction of the performance of biological systems (Kitano, 2002) . This approach has been applied for examining the codons usage profile of various organism and their adaptation to their hosts. Systems biology is also useful for predicting drugs for a given disease.

Systems biology has been recently applied for network-based drug repurposing for SARS-CoV-2 (Zhou et al., 2020) , but this study was solely based on phylogenetic approaches, and thus present some limitations in the understanding of the interaction between the virus and its host; this could introduce some biases in drug prediction. As a systems biology approach, network-pharmacology has been also used for evaluating the potential of traditional Chinese medicines against COVID-19 (Yu et al., 2020) . In analyzing dinucleotide over-and under-representation based on base model, codon and syncodon models. Details on these indices are described below.

The total GC content (percentage of G and C nucleotides relative to the total number of nucleotides), GC1 (percentage of G and C nucleotides at first position of codons), GC2 (percentage of G and C nucleotides at second position of codons) and GC3 (percentage of G and C nucleotides at second position of codons) were determined for each coding protein of SARS-CoV, SARS-CoV-2 or MERS-CoV and averaged.

Deviations in the ratio of dinucleotide pairs constitute an influential factor of codon usage (Kunec and Osterrieder, 2016; Sexton and Ebel, 2019) . The ratio of dinucleotide pairs is useful for gaging the preferential use of various dinucleotide pairs in an organism (Kunec and Osterrieder, 2016; Sexton and Ebel, 2019) . There are 16 dinucleotide combinations and the profiles of dinucleotide ratio can reflect mutational or selectional pressures. The ratio of dinucleotides was computed using the equation ρXY = fXY/fX*fY, wherein fX and fY stand for the frequencies of nucleotide X and nucleotide Y, respectively, whereas fXY is the frequency of XY dinucleotides in the same nucleotide sequence. The ratio of the factual to predicted dinucleotide frequency is the odds ratio. An odds ratio lower than 0.78 indicates underrepresented dinucleotide pairs while odds ratio greater than 1.25 indicates overrepresented dinucleotides (Kunec and Osterrieder, 2016).

The RSCU value of a given codon is the ratio of the observed value of this codon over the expected value of this codon for a given amino acid (Sharp and Li, 1986) . RSCU J o u r n a l P r e -p r o o f Journal Pre-proof value is independent from sequence length of the content in amino acid. Codons with RSCU greater than 1.6 are considered as preferred codons while codons with RSCU values lower than 0.6 are considered as non-preferential codons. Unbiased codons are those with RSCU ranging from 0.6 to 1.6. RSCU values were generated based on the CDS sequences of SARS-CoV, SARS-CoV-2, MERS-CoV and their hosts.

The similarity index (SiD) that assesses the impact of the codon usage of a given host on that of its pathogen. This approach is commonly used to gage the capacity of a host to give refuge to a virus (Zhou et al., 2013) . SiD is the effect of the overall codon usage of the host on that of its pathogens. SiD is comprised between 0 and 1, and high SiD values indicates greater effect of the host on codon usage of the pathogens. SiD values of SARS-CoV, SARS-CoV-2 and MERS-CoV were examined relative to their human host.

The effective number of codons (ENc), ranging between 20 and 61, is a codon usage index used for detecting the bias in the use of synonymous codons (Wright, 1990) .

ENc value = 20 when there is maximum bias and only one of the available synonymous codons is used for the encoding of a given amino acid. On the contrary, the maximum ENc value of 61 signposts no codon usage bias and indicates the same probability of the use of the available codons. ENc value < 35, indicates high codon usage bias in the genome.

To analyze the effect of the translation selection and mutation bias on the codon usage, we generated the neutrality plots for SARS-CoV, SARS-CoV-2 and MERS-CoV, J o u r n a l P r e -p r o o f Journal Pre-proof respectively. The regression line between GC12s and GC3s was generated and the slopes of the regression equations were used for evaluation the mutational force. The parity rule 2 (PR2)-bias plot was generated by plotting the three CoVs relative to human.

Codon adaptation index (CAI) is a numerical measure portraying the frequency of the use of a preferred codon among genes with high expression (Carbone et al., 2003; Lee et al., 2010) . CAI is used to assess the translation efficiency and finds application in the genetic engineering of nucleotide sequences optimal protein expression for vaccine development. Comprised between 0 and 1, elevated CAI values indicate greater gene expressivity and CAI values approximating the value of 1 signpost the use of codons with high RSCU values in the gene. We computed the CAI values of the CDS sequences of SARS-CoV, SARS-CoV-2 and MERS-CoV. RCDI (Mueller et al., 2006 ) is a numerical variable used for comparing the similarity in codon usage in genes and given genomes. RCDI can depict the rate of translation of viral gene in a host genome. Similar codon usage between a pathogen and its host is characterized by RCDI values close to 1, which indicates high translation rate and high adaptive capacity to the host (Butt et al., 2016) . RCDI values of the CDS sequences of SARS-CoV, SARS-CoV-2 and MERS-CoV for the host h. sapiens were determined.

the RSCU values of the CDS sequences of SARS-CoV, SARS-CoV-2, MERS-CoV and h. sapiens using the function dudi.pca in the ade4 R package.

Correspondence analysis was performed based on the RSCU values of the three viruses using the R packages "FactoMineR" and "factoextra".

The correlation between the RSCU values of human genes and those of viral genes was analyzed using the Hmisc library in R. The Pearson correlation coefficients and p values were generated for each pair of genes. The correlation significance was set for p <0.05.

The differential expression analysis of genes among uninfected and SARS-CoV-2infected human cell lines A549, A549-ACE2, Calu3 and NHBE was performed based on the GSE147507 data. The differential expression among uninfected and infected groups was analyzed using the DESeq library in R. The screening parameters of differentially expressed genes (DEGs) were as follows: |log2FC|≥1 and adjusted p value (p.adjust)>0.05. To uncover the true DEGs in response to SARS-CoV-2, the DEGs screened from the four cell lines were merge while for broader applicability, these DEGs were combined.

suggested that clinical and experimental practices based on SARS-CoV may be applicable to SARS-CoV-2, especially in the search for vaccines and treatment approaches.

To examine the compositional constraints in the genome of CoVs, the nucleotide compositions of the CDSs from MERS-CoV, SARS-CoV and SARS-CoV-2 were determined. The GC% content of the CDS sequences of MERS-CoV, SARS-CoV and SARS-CoV-2 ranged from 13.16% to 53.52% ( Figure 2A ). Most of the CDS sequences had GC content around 40% ( Figure 2A ). The histogram showing the distribution of GC1 ( Figure 2B ) indicated that most of the CDS sequences had GC1 content of 40-50% especially for MERS-CoV genome ( Figure 2B ). The lowest GC1 content was 15% while the highest was 69.01% ( Figure 2B ). Additionally, the CDS sequences with GC2 content of approximately 40% were the most abundant in the genomes of these CoVs with the lowest GC2 content of 12.56% and the highest GC2 content of 50.33% ( Figure 2C ). The lowest GC3 content was 11.84% while the GC3 content was 59.59% ( Figure 2D ). The CDS sequences with GC3 content between 20% and 40% were the most abundant ( Figure 2D ). As shown in Figure 

To determine codon pair preferences in CoV, we used three models for determining the underrepresented and the overrepresented dinucleotides. In the "base model" 

ENc values were computed to evaluate the intra-virus codon bias. Within SARS-CoV- and SARS-CoV ( Figure 4D ). For SARS-CoV-2, all the points were under the expected ENc curve, which suggested that selectional pressure is the exclusive factor influencing codon usage in SARS-CoV-2 ( Figure 4E ).

Neutrality plots of GC12 in function of GC3 was generated to assess the extent of mutational pressure on the usage of codons in CoVs. A correlation among GC12 and 2, respectively, suggesting that the relative neutrality (mutation pressure) was 10.29%, 9.92% and 20.02% for MERS-CoV, SARS-CoV and SARS-CoV-2 compared to relative natural selection constraints on GC3. The neutrality plot suggested that natural selection forces were stronger than mutational pressure. The analysis of the whole sequence after adaptation to human indicated that the CAI values of the genomic sequences after adaption were 0.957, 0.9511 and 0.9556, respectively (Additional Figure S1 ).

To assess the influence of the host (human) on codon usage by MERS-CoV, SARS-CoV and SARS-CoV-2, similarity index (SiD) was computed. SiD, ranging from 0 to 1, is an indicator of the similarities in codon usage among the virus and its host. The similarity indexes for MERS-CoV, SARS-CoV and SARS-CoV-2 were 0.4921, 0.4919 and 0.4919, respectively ( Figure 7A ). This indicated that the human genome had the highest effect on the MERS-CoV codon bias, followed by SARS-CoV and SARS-CoV-2, though there was no significant difference between the three viruses ( Figure 7A ). The parity plot was used to examine natural selection and mutation pressure in viral genes. Variation among A and T and among C and G contents was recorded for MERS-CoV ( Figure 7B ), SARS-CoV ( Figure 7C ) and SARS-CoV-2 ( Figure 7D ), signifying that not only natural selection but also mutation pressure cooperatively affect the codon usage bias of viral genes.

J o u r n a l P r e -p r o o f showing the profile of the codons in each viral gene and human cell is depicted in Figure 8A . It can be seen that numerous viral gene shared similar RSCU profile with human cell. In addition, after averaging the RSCU values of each viral genomes, we found that C-and G-ending codons were those generally preferred in human cell and other hosts compared to viral genes ( Figure 8B ). In addition, A-and T-ending codons were preferentially used in the viral genomes compared to the hosts ( Figure 8B ). In addition, as shown in Figure 8B , the three CoVs were clustered together on the basis of their RSCU values while their hosts were also clustered together. Moreover, a high similarity of RSCU values between the hosts was recorded ( Figure 8B ). The PCA plots of the A-ended, C-ended, G-ended and U-ended for MERS-CoV, SARS-CoV and SARS-CoV-2 based on the RSCU values was depicted in Additional Figure S2 .

In general, C-ended and G-ended codon were clustered together for each viral genome.

The correlation between codon on the basis of RSCU values were as depicted in Additional Figure S3 . To identify proteins which were shared similar RSCU pattern with the human cells, The PCA plot of genes was generated and indicated that membrane protein, matrix protein, membrane glycoprotein nucleocapsid protein and nucleocapsid phosphoprotein shared the most similar RSCU patterns with human cells ( Figure 9A ). To uncover the human genes that could be affected by the virus, we also generated the PCA plot based on the RSCU values of human genes and viral genes.

To identify the other factors that shape codon usage bias in CoVs, we performed correspondence analysis which is a statistical method used to study the variation of codon usage bias in genomes. Correspondence analysis reflects the distribution of genes and their corresponding codons, which helps identify potential factors MERS-CoV, we found that the contributions of the truncated Orf8B protein, the Orf8B protein, the Orf4A protein, the NS4A protein and the NS3B protein to the variation on the first and second axes were the most representative ( Figure 10B ). For SARS-CoV, the contributions of the hypothetical Orf10 protein, the Orf14 protein, the Orf9B protein, the Orf13 protein, the Orf8A protein and the Orf10 protein to the variation on the first and the second axis were higher than those of other proteins ( Figure 10D ). For SARS-CoV-2, the contributions of the Orf10 protein, the Orf6 J o u r n a l P r e -p r o o f Journal Pre-proof protein, the Orf7B protein and the envelope protein to the variation on the first and the second axis were more important than those of other proteins ( Figure 10F ).

Further, we performed Pearson correlation between human genes and viral genes.

Human genes showing correlation r with p<0.05 were retained for subsequent analysis. In total, 14091 human genes were correlated with viral genes (Additional 

In order to further confirm the potential genes affected by SARS-CoV-2, we performed differential expression analysis between uninfected and SARS-CoV-2- Figure   13B ). The most representative molecular functions were cytokine receptor binding, oligosaccharide binding, and CCR chemokine receptor binding (GO-MF, Figure 13C ).

The most representative pathways were rheumatoid arthritis, TNF signaling pathway, African trypanosomiasis, malaria, IL-17 signaling pathway, viral protein interaction with cytokine and cytokine receptor, AGE-RAGE signaling pathway in diabetic complications, and influenza related pathways ( Figure 13D ).

Using panobinostat (12 target genes), romidepsin (12 target genes), valproic acid (12 target genes) and vorinostat (12 target genes) were those with the highest number of target genes. We inferred that the list of drugs found in this study could be useful for the treatment of COVID-19. The occurrence of dinucleotide codons is a defining variable for evaluating mutational and codon usage biases as well as the effect of compositional constraints and selective pressure in a given genome (Ellis et al., 1993; Smutzer and Chamberlin, 1994; Yamagishi et al., 2002) . Studies have shown that the relative abundance of dinucleotides has a strong influence on the use of viral codons (Tan et al., 2004) . GC dinucleotide depletion is a selective force that has a direct impact on the frequency of GC dinucleotide codons (Johnson, 1990; Tan et al., 2004) . In the present study, we

found an under-representation of GC dinucleotides. This low GC dinucleotide frequency is a strategy of the virus to avoid host immunization that identifies any sequence containing unmethylated GC dinucleotides as an antigen to be degraded (Vetsigian and Goldenfeld, 2009; Woo et al., 2007) . In addition, the low frequency of GC dinucleotides may be a direct cause of methylation of cytosine residues induced by genetic events such as X chromosome inactivation, genetic silencing and genetic J o u r n a l P r e -p r o o f fingerprinting (Li and Zhang, 2014; Zhang et al., 2014) . Spontaneous deamination of methylated cytosines into thymine may therefore lead to low levels of GC

dinucleotides. An under-representation of GC dinucleotides has been similarly observed in the genome of various viruses (Castells et al., 2017; Rothberg and Wimmer, 1981; Tan et al., 2004) . Studies indicate that artificially increasing the frequency of GC dinucleotides attenuates the virus and inhibits its replication (Takata et al., 2017) . This approach could be adopted in the search for vaccines against respiratory viruses such as the SARS-CoV2 responsible for COVID-19.

The mean GC3 contents were 0.29, 0.35 and 0.35 for SARS-CoV-2, SARS-CoV and MERS-CoV, respectively. If the use of the codon is only affected by the GC3 content, there is mutation pressure and, in this case, the ENc value is above the predicted ENc curve (Gu et al., 2004; Zhong et al., 2007) . In all three genomes of MERS-CoV,

were below the predicted ENc curve, suggesting that selection pressure is the main force impacting codon utilization in these viruses. For SARS-CoV-2, ENc values for some CDS sequences were above the expected ENc curve, suggesting that these sequences are under the force of mutational pressure. Subsequently, we also examined the role of selection pressure using neutrality plots. A significant correlation between GC12 and GC3 with a slope of the regression line around 1 indicates that the mutation pressure is the key coefficient that affects codon use. On the other hand, a slope of zero or close to the horizontal line suggests that selection pressure is the major factor influencing codon use. The slopes of the regression lines were 1.029, 0.992 and 2.002

for MERS-CoV, SARS-CoV and SARS-CoV-2, respectively, indicating that the force of natural selection takes precedence over the force of mutation. Currently, the mechanism underlying the pathogenesis of COVID-19 is unknown.

Making use of the results obtained in the present study, we found human genes that could be affected by viral (SARS-CoV-2, SARS-CoV and MERS-CoV) genes. Currently, there is no precise therapy for treating the ongoing COVID-19. Here, we predicted a set of drugs that could be efficient in the treatment of COVID-19 and other CoV infections. In the early search of treatment for SARS-CoV-2 infection, researchers have proposed hydroxycholoroquine and chloroquine as treatment for COVID-19 (Singh et al., 2020) . Our study also predicted these drugs as a treatment for COVID-19 and other CoV infections. However, the limited number of genes targeted by these drugs indicated that their efficiencies may be limited. Nevertheless, these results ascertain the credibility of the present study. In our study, we found that some drugs had huge numbers of target genes. Thus, we suggested that these drugs Nicotinamide has also been shown to be an antimicrobial agent with activity against the tuberculosis pathogen (mycobacterium tuberculosis) and the human immunodeficiency virus (HIV) (Murray, 2003) . Reports of other scientific research indicate that ethanol, through its inducing action on lipid metabolism and NADH/NAD+, is effective in inhibiting the replication of the hepatitis C virus (Seronello et al., 2010) . Our study also found alcohol as a potential drug against CoV

infections. However, this should be dealt with caution as studies have shown that alcohol regulates the inflammatory and anti-viral activities of monocytes but that prolonged alcohol consumption reduces the anti-viral activity of interferon type 1 (IFN) while inducing inflammation through modulation of the pro-inflammatory cytokine TNFα (Pang et al., 2011) . Our study uncovered L-GLUTAMATE as a potential therapeutic drug for CoV infections. Our results reaffirm those of previous studies stating that glutamate plays an important role against viral infections such as HIV-1 (Erdmann et al., 2007) and HIV-1 associated neuro-invasive dementia (Zhao et al., 2004) . Thus, we believe that its administration to CoV-infected patients will probably be salutary for patients especially due to the fact that studies have demonstrated that the neuroinvasive ability of SARS-CoV2 is partially associated with the respiratory failure of COVID-19 patients (Li et al., 2020) .

Taken together, our study predicted a panoply of drugs with potential in the treatment The circos plot was generated using circolleto in viruSITE. 

Imbalanced Host Response to SARS-CoV-2

Drives Development of COVID-19

Evolutio n of codon usage in Zika virus genomes is host and vector specific

Codon adaptation index as a measure of dominating codon bias

COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection

Genome-wide analysis of codon usage bias in Bovine Coronavirus

In Silico Discovery of Candidate Drugs against Covid-19

Analysis of the codon usage pattern in Middle East Respiratory Syndrome Coronavirus

DGIdb 3.0: a redesign and expansion of the drug-gene interaction database

Inhibition of TLR8-and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes

Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus

Mononucleotide and dinucleotide frequencies, and codon usage in poliovirion RNA

Effects of Arbovirus Multi-Host Life Cycles on Dinucleotide and Codon Usage Patterns. Viruses 11

An evolutionary perspective on synonymous codon usage in unicellular organisms

Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Host NAD+ metabolism and infections: therapeutic implications

Dinucleotide frequencies and codon usage in jawless and cartilaginous fishes

viruSITE-integrated database for viral genomics

Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses

Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?

The 'effective number of codons' used in a gene

Genome Composition and Divergence of the Novel Coronavirus

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Full-genome sequences of the first two SARS-CoV-2 viruses from India

Evolutionary changes of the novel Influenza D virus hemagglutinin-esterase fusion gene revealed by the codon usage pattern

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Analysis of Synonymous Codon Usage Bias in Flaviviridae Virus

clusterProfiler: an R package for comparing biological themes among gene clusters

Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19

Biased codon usage in signal peptides: a role in protein export

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection

HIV-1-infected macrophages: linkage to HIV-1 associated dementia

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Mutation pressure shapes codon usage in the GC-Rich genome of foot-and-mouth disease virus

The distribution of synonymous codon choice in the translation initiation region of dengue virus

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 6, 14